Stockholders’ Equity (Details) - USD ($)													2 Months Ended	12 Months Ended
Stockholders’ Equity (Details) - USD ($)	Nov. 13, 2025	Aug. 28, 2025	Aug. 27, 2025	Jun. 04, 2025	Jan. 14, 2025	Jan. 13, 2025	Jan. 07, 2025	Aug. 19, 2024	Apr. 01, 2024	Mar. 27, 2024	Jan. 08, 2024	Jan. 05, 2024	Dec. 31, 2024	Dec. 31, 2025	Dec. 31, 2024	Sep. 23, 2025	May 09, 2025	Feb. 07, 2025	Jan. 06, 2025	May 15, 2024	Jan. 04, 2024	Dec. 31, 2023	Jun. 02, 2023	Jan. 11, 2023	Nov. 02, 2022	Mar. 24, 2022	Feb. 02, 2022	Jun. 24, 2021	Jan. 01, 2021	May 04, 2018
Stockholders’ Equity [Line Items]
Preferred stock, shares authorized													10,000,000	10,000,000	10,000,000
Preferred stock, shares undesignated													3,000,000	3,000,000	3,000,000
Preferred stock, par value (in Dollars per share)													$ 0.0001	$ 0.0001	$ 0.0001
Proceeds from warrants (in Dollars)														$ 5,625,000	$ 3,682,300
Exercise price per warrant (in Dollars per share)				$ 1
Warrants issued				300,000
Fair value of warrants (in Dollars)				$ 333,150
Common shares issued											55,675
Stock-based professional fees (in Dollars)														$ 333,150
Warrant shares issued														2,500,000
Issuance of warrants														2,500,000
Common shares value (in Dollars)						$ 850,500							$ 804	$ 1,551	804
Share price (in Dollars per share)						$ 1.89
Agreement amount (in Dollars)	$ 4,821,200
Net proceeds														$ 4,118,865
Common stock issued for compensation														800,000
Common stock withheld for payroll taxes (in Shares)														310,744
Shares reserved																	3,091,317
Share price per share (in Dollars per share)																$ 0.034
Stock-based compensation (in Dollars)														$ 1,521,079	$ 804,277
Stock option exercise price (in Dollars per share)													$ 4.78	$ 4.34	$ 4.78							$ 26.78
Aggregate grant date fair value options (in Dollars)														$ 111,250
Aggregate grant date fair value of options (in Dollars)								$ 281,388
Stock-based compensation expense relating to unvested stock options (in Dollars)														$ 0
Preferred stock, shares issued													0	0	0
Preferred stock, shares outstanding													0	0	0
Aggregate sales price	10,139,256													$ 4,118,865	$ 1,060,719
January 2023 Existing Warrants [Member]
Stockholders’ Equity [Line Items]
Aggregate warrants										2,500,000
Reduced exercise price (in Dollars per share)									$ 1.6775	$ 1.6775
Proceeds from warrants (in Dollars)										$ 4,194,000
Exercise price per warrant (in Dollars per share)									$ 2.0969	$ 5
Warrant expiration date									Jul. 03, 2028
Warrants issued									125,000
Warrants amount (in Dollars)										$ 550,500
Net proceeds (in Dollars)									$ 3,682,000
Other offering expenses (in Dollars)									$ 512,000
April 2024 Inducement Warrants [Member]
Stockholders’ Equity [Line Items]
Exercise price per warrant (in Dollars per share)														$ 1.5
Unregistered warrants to purchase shares														3,750,000
Warrant expiration date														Jul. 03, 2028
Warrants issued									3,750,000
Fair value of warrants (in Dollars)									$ 4,166,800
Warrant [Member]
Stockholders’ Equity [Line Items]
Aggregate warrants													2,500,000		2,500,000
Proceeds from warrants (in Dollars)									$ 4,194,000
Common Stock Warrants [Member]
Stockholders’ Equity [Line Items]
Aggregate grant date fair value of options (in Dollars)					$ 219,929
2018 Equity Incentive Plan [Member]
Stockholders’ Equity [Line Items]
Shares reserved																													26,878	40,000
Common stock available for grant														738
2022 Equity Incentive Plan [Member]
Stockholders’ Equity [Line Items]
Preferred stock, shares designated																	2,000,000
Shares reserved																	1,091,317			500,000			495,317			96,000
Common stock available for grant														1,201,317
Share price per share (in Dollars per share)			$ 1.21
Options issued to purchase shares					77,000			473,000
Stock option exercise price (in Dollars per share)					$ 1.55			$ 0.7548
Preferred Stock [Member]
Stockholders’ Equity [Line Items]
Preferred stock, shares undesignated													3,000,000	3,000,000	3,000,000
Common Stock [Member]
Stockholders’ Equity [Line Items]
Common shares issued											55,675			2,782,309	1,137,250
Aggregate sales price														$ 278	$ 114
Common Stock [Member] \| April 2024 Inducement Warrants [Member]
Stockholders’ Equity [Line Items]
Net proceeds (in Dollars)							$ 5,625,000
Common shares issued							3,750,000
Exercise of shares							3,750,000
Common Stock [Member] \| September 2023 Pre-funded Warrants [Member]
Stockholders’ Equity [Line Items]
Warrants issued											55,675
Common Stock [Member] \| 2018 Equity Incentive Plan [Member]
Stockholders’ Equity [Line Items]
Shares reserved																													66,878
Patent Application Acquisition Agreement [Member]
Stockholders’ Equity [Line Items]
Common shares issued						450,000
Cash payment (in Dollars)						$ 400,000
Common shares value (in Dollars)						$ 850,500
Share price per share (in Dollars per share)						$ 1.89
Aggregate sales price						$ 1,250,500
ATM Agreement [Member]
Stockholders’ Equity [Line Items]
Common shares issued													1,137,250	2,782,309
Agreement amount (in Dollars)	$ 2,439,256																	$ 5,000,000
Net proceeds													$ 1,061,000	$ 4,118,865
Restricted Stock Awards [Member]
Stockholders’ Equity [Line Items]
Stock-based compensation (in Dollars)														$ 968,000	2,543
Restricted Stock Awards [Member] \| 2022 Equity Incentive Plan [Member]
Stockholders’ Equity [Line Items]
Common stock issued for compensation			800,000
Stock Options [Member]
Stockholders’ Equity [Line Items]
Options issued to purchase shares					93,000							450,000
Stock option exercise price (in Dollars per share)					$ 1.55							$ 1.36
Aggregate grant date fair value options (in Dollars)													$ 512,685		$ 512,685
Chief Executive Officer [Member]
Stockholders’ Equity [Line Items]
Net Shares issued														489,256
Chief Executive Officer [Member] \| Common Stock [Member]
Stockholders’ Equity [Line Items]
Common stock issued for compensation		800,000
Common stock issued for compensation (in Dollars)														$ 968,000
Common stock withheld for payroll taxes (in Shares)														310,744
Common stock withheld for payroll taxes (in Dollars)														$ 376,000
Minimum [Member] \| 2018 Equity Incentive Plan [Member]
Stockholders’ Equity [Line Items]
Shares reserved																												66,878
Minimum [Member] \| 2018 Equity Incentive Plan [Member] \| Board of Directors [Member]
Stockholders’ Equity [Line Items]
Shares reserved																			176,878		166,878			156,878			146,878
Minimum [Member] \| 2022 Equity Incentive Plan [Member]
Stockholders’ Equity [Line Items]
Shares reserved																				591,317
Maximum [Member] \| 2018 Equity Incentive Plan [Member]
Stockholders’ Equity [Line Items]
Shares reserved																												146,878
Maximum [Member] \| 2018 Equity Incentive Plan [Member] \| Board of Directors [Member]
Stockholders’ Equity [Line Items]
Shares reserved																			186,878		176,878			166,878			156,878
Maximum [Member] \| 2022 Equity Incentive Plan [Member]
Stockholders’ Equity [Line Items]
Shares reserved																				1,091,317
Series A Convertible Preferred Stock [Member]
Stockholders’ Equity [Line Items]
Preferred stock, shares designated													5,000,000	5,000,000	5,000,000
Preferred stock, par value (in Dollars per share)													$ 0.0001	$ 0.0001	$ 0.0001
Preferred stock, shares issued													0	0	0
Preferred stock, shares outstanding													0	0	0
Series B Preferred Stock [Member]
Stockholders’ Equity [Line Items]
Preferred stock, shares designated													2,000,000	2,000,000	2,000,000
Preferred stock, par value (in Dollars per share)													$ 0.0001	$ 0.0001	$ 0.0001
Preferred stock, shares issued													0	0	0
Preferred stock, shares outstanding													0	0	0
Series B Preferred Stock [Member] \| Preferred Stock [Member]
Stockholders’ Equity [Line Items]
Preferred stock, shares authorized																									2,000,000
Preferred stock, par value (in Dollars per share)																									$ 0.0001

Hoth Therapeutics, Inc. 10-K